KCCure Innovation Awards (Ongoing Program)
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Overview
Program Type: Ongoing innovation research grants for cutting-edge scientific research in kidney cancer
Program Description
KCCure announced the inaugural Kidney Cancer Innovation Research Grant Award in 2017. Since then, $400,000 in Innovation Research Grants have been awarded to top institutions.
Focus Areas
- Cutting-edge, innovative scientific research in kidney cancer
- Novel therapeutic approaches and breakthroughs
- Research addressing unmet clinical needs
Past Award Recipients & Projects
- 2017 Innovation Award Winner: Wayne A. Marasco, MD, PhD, Dana-Farber Cancer Institute, Harvard Medical School
- Project: "CAR T Cell Factories that Change the Tumor Microenvironment to Achieve RCC Cures"
- 2018 Innovation Award Winner: Qing Zhang, MD, PhD, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
- Project: "TBK1 Serves as a Novel Therapeutic Target in Kidney Cancer with VHL Loss"
Institutions Receiving Awards
- Dana Farber
- MD Anderson
- UT Southwestern
- University of North Carolina
- National Cancer Institute
- Thomas Jefferson University
Application & Updates
- Information about new awards and RFPs updated as they are released
- For researcher inquiries about funding opportunities, contact grants@kccure.org
How to Apply
Application Process
- Stay informed: Information about new RFPs released as they become available on kccure.org/grants/
- Contact KCCure for opportunities: Researchers interested in discussing funding opportunities should contact grants@kccure.org
- Watch for RFP announcements: New RFPs and deadlines posted on KCCure website
Contact
Email: grants@kccure.org
Website: kccure.org/grants/
For current RFP details, deadlines, and application requirements, contact KCCure directly or check the website for latest announcements.
What Kidney Cancer Research Alliance Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 2
- Total given
- $75K
- Median grant
- $38K
- Range
- $25K–$50K
- By dollars: Massachusetts 67%, Texas 33%. Top recipient cities: Boston, MA; Houston, TX.
Example grants
Brigham & Womens Hospital · Boston, MA
Cancer research
$50K
MD Anderson · Houston, TX
Cancer research
$25K
Focus Areas & Funding Uses
Fields of Work
- Cancer
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Amount
Up to $200,000
Deadline
November 17, 2026
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Amount
$3,400,000 total
Deadline
November 23, 2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Ready to apply for KCCure Innovation Awards (Ongoing Program)?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found KCCure Innovation Awards (Ongoing Program). Now let's win it.